Clinical Trial Update: Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating molecular profiling-guided matched targeted therapy in patients with unresectable advanced or metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Melanoma | Phase 2 | Status: COMPLETED